Concentrix Corporation
NASDAQ:CNXCInformation Technology Services
-$0.75 today
- Market cap
- $1.85B
- Beta
- 0.42
- P/E (TTM)
- -1.1
- EPS (TTM)
- -$21.66
- Dividend yield
- 5.73%
Volume 0.65M
Average 1.64M
CNXC Accounts Receivables
Cash effect of the change in amounts owed by customers; growing receivables consume cash.
Concentrix CorporationNASDAQ: CNXC
Accounts Receivables · Q1 FY2026 · quarter ended Feb 2026
Accounts receivables dips below year-ago levels
Q1 FY2026 accounts receivables of $21.13M (cash outflow) fell 80.2% year over year, behind the +149.8% change in trailing-twelve-month accounts receivables. Over 3 fiscal years it compounded at -24.3% a year.
Context
- Accounts receivables amounted to 0.2% of revenue in FY2025, down 0.4 pp from a year earlier.
- Accounts receivables grew in size in 1 of the last 3 fiscal years.
- FY2025 was the smallest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly growth recovers from -80.2% toward the trailing-twelve-month pace of +149.8%.
Sources:Cash FlowText generated from reported figures; not investment advice.
Accounts Receivables history
USD · from the cash flow
- Latest · FY2025
- (23.08M) USD
- Year-over-year change
- +63.9%
| Period | Period end | Accounts Receivables | YoY change |
|---|---|---|---|
| FY2025 | 2025-11-30 | (23.08M) | +63.9% |
| FY2024 | 2024-11-30 | (63.85M) | -39.1% |
| FY2023 | 2023-11-30 | (45.9M) | +13.6% |
| FY2022 | 2022-11-30 | (53.13M) | +61.8% |
| FY2021 | 2021-11-30 | (139.1M) | — |
Accounts Receivables vs competitors
How CNXC compares with its peers on the latest reported figures
- CNXC's LTM Feb 2026 accounts receivables of $62.7M is the 3rd largest of the 9 companies compared; the peer median is $11.53M.
- Its year-over-year change of +149.8% is the 2nd highest of 9, against a peer median of +83.0%.
- Accounts receivables amounts to 0.6% of revenue for CNXC, versus a peer median of 1.6%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Sep 2026 | $98.37M | +84.3% | -28.9% | 1.7% | |
| LTM Jun 2026 | $90.98M | +566.1% | -19.2% | 4.1% | |
| LTM Feb 2026 | $62.7M | +149.8% | -24.3% | 0.6% | |
| LTM Mar 2026 | $28.7M | +81.6% | -43.9% | 1.2% | |
| LTM Jun 2026 | $13.5M | -17.8% | — | 4.3% | |
| LTM Mar 2026 | $12.37M | +130.3% | — | 0.6% | |
| LTM Mar 2026 | $9.57M | -44.3% | +25.7% | 1.5% | |
| LTM Mar 2026 | $6.65M | -60.9% | +8.4% | 1.6% | |
| LTM Apr 2026 | $6.16M | +122.4% | — | 0.7% | |
| Peer median (excluding CNXC) | $11.53M | +83.0% | -19.2% | 1.6% | |
Competitors are the stored peer set for CNXC. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Nov 2021 | FY2022 Nov 2022 | FY2023 Nov 2023 | FY2024 Nov 2024 | FY2025 Nov 2025 |
|---|---|---|---|---|---|
| Net Income | 405.58M | 435.64M | 313.84M | 251.22M | (1.28B) |
| Depreciation & Amortization | 277.18M | 309.54M | 388.3M | 705.85M | 660.43M |
| Deferred Income Tax | (25.73M) | (30.82M) | (121.71M) | (235.25M) | (154.88M) |
| Stock-Based Compensation | 36.18M | 47.14M | 62.11M | 96.06M | 96.39M |
| Change in Working Capital | (165.46M) | (165.02M) | (10.66M) | (166.89M) | (85.76M) |
| Accounts Receivables | (139.1M) | (53.13M) | (45.9M) | (63.85M) | (23.08M) |
| Inventory | (22.83M) | 0 | 0 | 0 | 0 |
| Accounts Payables | (4.55M) | 14.63M | 9.34M | (25.82M) | 28.47M |
| Other Working Capital | 1.02M | (126.51M) | 25.9M | (77.22M) | (91.16M) |
| Other Non-Cash Items | (13.56M) | 4.24M | 46.13M | 16.51M | 1.57B |
| Operating Cash Flow | 514.18M | 600.72M | 678.01M | 667.49M | 806.97M |
| Capital Expenditures | (149.08M) | (140.02M) | (180.53M) | (238.76M) | (234.5M) |
| Acquisitions (Net) | 70.43M | (1.7B) | (1.91B) | (5.5M) | (15.89M) |
| Purchases of Investments | 0 | (1M) | 0 | 0 | 0 |
| Sales of Investments | 0 | 1M | 0 | 0 | 0 |
| Other Investing Activities | 0 | (1M) | (14.63M) | 0 | 0 |
| Investing Cash Flow | (78.65M) | (1.84B) | (2.11B) | (244.27M) | (250.38M) |
| Debt Repayment | (345M) | 1.43B | 1.98B | (208.69M) | (196.69M) |
| Common Stock Issued | 0 | 0 | 0 | 0 | 3.98M |
| Common Stock Repurchased | (57.49M) | (133.29M) | (81.19M) | (149.48M) | (188.71M) |
| Dividends Paid | (13.08M) | (53.43M) | (63.5M) | (83.81M) | (89.62M) |
| Other Financing Activities | 13.7M | (2.24M) | (36.63M) | (50.56M) | (20.4M) |
| Financing Cash Flow | (401.87M) | 1.24B | 1.8B | (492.53M) | (491.44M) |
| Effect of Forex Changes | (7M) | (24.52M) | (12.42M) | (17.58M) | 26.38M |
| Net Change in Cash | 26.66M | (25.55M) | 359.02M | (86.88M) | 91.52M |
| Free Cash Flow | 365.1M | 460.7M | 497.48M | 428.73M | 572.47M |
Concentrix Corporation
NASDAQ:CNXC
Intrinsic Alpha fair value
Locked
Current Price
$30.27
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.